Impact of infarct location on left ventricular ejection fraction after correction for enzymatic infarct size in acute myocardial infarction treated with primary coronary intervention

被引:27
作者
Elsman, Peter
van't Hof, Arnaud W. J.
de Boer, Menko-Jan
Suryapranata, Harry
Borm, George F.
Hoorntje, Jan C. A.
Ottervanger, Jan Paul
Gosselink, A. T. Marcel
Dambrink, Jan-Henk F.
Zijlstra, Felix
机构
[1] Univ Utrecht, Med Ctr, Dept Cardiol, NL-3584 CX Utrecht, Netherlands
[2] Isala Klin, Dept Cardiol, Zwolle, Netherlands
[3] Univ Utrecht, Med Ctr, Dept Cardiol, NL-3508 TC Utrecht, Netherlands
[4] Univ Nijmegen, Radboud Med Ctr, Dept Epidemiol & Biostat, Nijmegen, Netherlands
关键词
D O I
10.1016/j.ahj.2005.12.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Left ventricular function and infarct size are strong predictors for prognosis after acute myocardial infarction (MI). Anterior MI is associated with greater reduction of left ventricular ejection fraction (LVEF) and worse prognosis. Our objective was to study whether the impact of infarct size on global LVEF is dependent of infarct location. Methods We analyzed 888 patients treated with primary percutaneous coronary intervention for acute Mi. Enzymatic infarct size and LVEF within 1 week were measured. In 490 patients (55%), LVEF was measured a second time at 6 months. Results Every 1000 U/L of cumulative lactate clehydrogense release corresponded to a decrease of 4.7% (95% CI 4.1-5.3) in LVEF measured within 1 week post MI for left anterior descending coronary artery (LAD)-related infarcts and to a decrease of 2.4% (95% CI 1.7-3.1) in LVEF measured within 1 week post MI for non-LAD-related infarcts (P <.0001). Left ventricular ejection fraction measured 6 months post Mi showed a decrease for every 1000 U/L cumulative lactate clehydrogense release of 4.8% (95% CI 4.2-5.3) for LAD and 2.4% (95% CI 1.7-3.1) for non-LAD-related infarcts (P <.0001). Multivariate correction for relevant clinical and angiographic data did not change these results. Conclusion In patients with a first acute Mi treated with primary percutoneous coronary intervention, LAD-related infarcts show for a similar amount of myocardial necrosis as determined by enzymatic infarct size, a lower residual LVEF when compared with non-LAD-related inforcts.
引用
收藏
页码:1239.e9 / 1239.e14
页数:6
相关论文
共 30 条
[1]   A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction [J].
Andersen, HR ;
Nielsen, TT ;
Rasmussen, K ;
Thuesen, L ;
Kelbaek, H ;
Thayssen, P ;
Abildgaard, U ;
Pedersen, F ;
Madsen, JK ;
Grande, P ;
Villadsen, AB ;
Krusell, LR ;
Haghfelt, T ;
Lomholt, P ;
Husted, SE ;
Vigholt, E ;
Kjaergard, HK ;
Mortensen, LS .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (08) :733-742
[2]   A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction [J].
Antoniucci, D ;
Rodriguez, A ;
Hempel, A ;
Valenti, R ;
Migliorini, A ;
Vigo, F ;
Parodi, G ;
Fernandez-Pereira, C ;
Moschi, G ;
Bartorelli, A ;
Santoro, GM ;
Bolognese, L ;
Colombo, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (11) :1879-1885
[3]   THE RELATIONSHIPS AMONG VENTRICULAR ARRHYTHMIAS, LEFT-VENTRICULAR DYSFUNCTION, AND MORTALITY IN THE 2 YEARS AFTER MYOCARDIAL-INFARCTION [J].
BIGGER, JT ;
FLEISS, JL ;
KLEIGER, R ;
MILLER, JP ;
ROLNITZKY, LM .
CIRCULATION, 1984, 69 (02) :250-258
[4]  
Brener SJ, 2000, AM HEART J, V139, P476, DOI 10.1067/mhj.2000.102197
[5]   THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) TRIAL, PHASE-I - A COMPARISON BETWEEN INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND INTRAVENOUS STREPTOKINASE - CLINICAL FINDINGS THROUGH HOSPITAL DISCHARGE [J].
CHESEBRO, JH ;
KNATTERUD, G ;
ROBERTS, R ;
BORER, J ;
COHEN, LS ;
DALEN, J ;
DODGE, HT ;
FRANCIS, CK ;
HILLIS, D ;
LUDBROOK, P ;
MARKIS, JE ;
MUELLER, H ;
PASSAMANI, ER ;
POWERS, ER ;
RAO, AK ;
ROBERTSON, T ;
ROSS, A ;
RYAN, TJ ;
SOBEL, BE ;
WILLERSON, J ;
WILLIAMS, DO ;
ZARET, BL ;
BRAUNWALD, E .
CIRCULATION, 1987, 76 (01) :142-154
[6]   PROGNOSTIC VALUE OF EXERCISE TESTING, CORONARY ANGIOGRAPHY AND LEFT VENTRICULOGRAPHY 6-8 WEEKS AFTER MYOCARDIAL-INFARCTION [J].
DEFEYTER, PJ ;
VANEENIGE, MJ ;
DIGHTON, DH ;
VISSER, FC ;
DEJONG, J ;
ROOS, JP .
CIRCULATION, 1982, 66 (03) :527-536
[7]  
DEZWAAN C, 1988, BRIT HEART J, V59, P175
[8]   Estimation of enzymatic infarct size:: Direct comparison of the marker enzymes creatine kinase and α-hydroxybutyrate dehydrogenase [J].
Dissmann, R ;
Linderer, T ;
Schröder, R .
AMERICAN HEART JOURNAL, 1998, 135 (01) :1-9
[9]   TIME COURSE OF FUNCTIONAL AND BIOCHEMICAL RECOVERY OF MYOCARDIUM SALVAGED BY REPERFUSION [J].
ELLIS, SG ;
HENSCHKE, CI ;
SANDOR, T ;
WYNNE, J ;
BRAUNWALD, E ;
KLONER, RA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1983, 1 (04) :1047-1055
[10]   The predictive value of cumulative lactate dehydrogenase release within the first 72 h of acute myocardial infarction in patients treated with primary angioplasty [J].
Elsman, P ;
Zijlstra, F ;
Miedema, K ;
Hoorntje, JC ;
Dikkeschei, LD ;
Slingerland, RJ ;
Reiffers, S ;
de Boer, MJ ;
Suryapranata, H .
ANNALS OF CLINICAL BIOCHEMISTRY, 2004, 41 :142-148